Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Hesse

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
ACS Central Science|May 30, 2023
Rational Chemical Design of Molecular Glue DegradersEthan S Toriki, James W Papatzimas, Kaila Nishikawa, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Chembiochem : a European Journal of Chemical Biology|April 18, 2023
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease InhibitorsPatrick Moon, Charlotte M Zammit, Qian Shao, et al.
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
ACS Central Science|May 30, 2023
Rational Chemical Design of Molecular Glue DegradersEthan S Toriki, James W Papatzimas, Kaila Nishikawa, et al.
Antimicrobial Agents and Chemotherapy|December 19, 2025
Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerizationVincent H J Leonard, Dianna B Vidales, Benjamin R Taft, et al.
Chembiochem : a European Journal of Chemical Biology|April 18, 2023
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease InhibitorsPatrick Moon, Charlotte M Zammit, Qian Shao, et al.
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Pageof 2